Agency Forms Undergoing Paperwork Reduction Act Review, 23498-23499 [2016-09189]

Download as PDF jstallworth on DSK7TPTVN1PROD with NOTICES 23498 Federal Register / Vol. 81, No. 77 / Thursday, April 21, 2016 / Notices reasonable likelihood that such radiation doses may have endangered the health of members of this class. SPR was established to aid the Advisory Board in carrying out its duty to advise the Secretary, HHS, on dose reconstruction. SPR is responsible for overseeing, tracking, and participating in the reviews of all procedures used in the dose reconstruction process by the NIOSH Division of Compensation Analysis and Support (DCAS) and its dose reconstruction contractor (Oak Ridge Associated Universities—ORAU). Matters for Discussion: The agenda for the Subcommittee meeting includes: Discussion of procedures in the following ORAU and DCAS technical documents: OCAS Technical Information Bulletin (TIB) 0014 (‘‘Rocky Flats Internal Dosimetry Coworker Extension’’), ORAU OTIB 0013 (‘‘Individual Dose Adjustment Procedures for Y–12 Dose Reconstructions’’), ORAU OTIB 0029 (‘‘Internal Dose Reconstructions for Y– 12’’), ORAU OTIB 0039 (‘‘Internal Dose Reconstructions for Hanford’’), ORAU OTIB 0050 (‘‘The Use of Rocky Flats Neutron Dose Reconstruction Project Data in Dose Reconstructions’’), ORAU OTIB 0060 (‘‘Internal Dose Reconstructions’’), Program Evaluation Report (PER) 003 (‘‘The Effects of Adding Ingestion Intakes to Bethlehem Steel Cases’’), PER 004 (‘‘Application of Photofluorography at the Pinellas Plant’’), PER 005 (‘‘Misinterpreted Application of External Dose Factor for Hanford Dose Reconstructions’’), PER 029 (‘‘Hanford TBD Revision’’), PER 042 (‘‘Linde Ceramic Plant TBD Revision’’), PER 045 (‘‘Aliquippa Forge TBD Revision’’), ORAU PROC 0042 (‘‘Incomplete Monitoring at Y–12’’), ORAU RPRT 0044 (‘‘Analysis of Bioassay Data with Significant Fraction of Less-Than Results’’); and a continuation of the comment-resolution process for other dose reconstruction procedures under review by the Subcommittee. The agenda is subject to change as priorities dictate. Contact Person For More Information: Theodore Katz, Designated Federal Officer, NIOSH, CDC, 1600 Clifton Road, Mailstop E–20, Atlanta, Georgia 30329–4027, Telephone (513) 533–6800, Toll Free 1(800) CDC–INFO, Email ocas@cdc.gov. The Director, Management Analysis and Services Office, has been delegated the authority to sign Federal Register notices pertaining to announcements of meetings and other committee management activities, for both the Centers for Disease Control and VerDate Sep<11>2014 13:27 Apr 20, 2016 Jkt 238001 Prevention and the Agency for Toxic Substances and Disease Registry. DEPARTMENT OF HEALTH AND HUMAN SERVICES Elaine L. Baker, Director, Management Analysis and Services Office, Centers for Disease Control and Prevention. Centers for Disease Control and Prevention [FR Doc. 2016–09268 Filed 4–20–16; 8:45 am] Agency Forms Undergoing Paperwork Reduction Act Review BILLING CODE 4163–19–P DEPARTMENT OF HEALTH AND HUMAN SERVICES Centers for Disease Control and Prevention Disease, Disability, and Injury Prevention and Control Special Emphasis Panel (SEP): Initial Review The meeting announced below concerns the CDC National Centers for Excellence in Youth Violence Prevention: Operations Research (Implementation Science) for Strengthening Program Implementation through the President’s Emergency Plan for AIDS Relief (PEPFAR), RFA–GH–16– 005, initial review. This publication corrects a notice that was published in the Federal Register on March 22, 2016 Volume 81, Number 55, pages 15307. The meeting place should read as follows: SUMMARY: DATES: Times and Dates: 9:00 a.m.–2:00 p.m., EDT, Panel A, April 26, 2016 (Closed) 9:00 a.m.–2:00 p.m., EDT, Panel B, April 27, 2016 (Closed) FOR FURTHER INFORMATION CONTACT: Hylan Shoob, Scientific Review Officer, Center for Global Health (CGH) Science Office, CGH, CDC, 1600 Clifton Road NE., Mailstop D–69, Atlanta, Georgia 30033, Telephone: (404) 639–4796, HMS4@CDC.GOV. The Director, Management Analysis and Services Office, has been delegated the authority to sign Federal Register notices pertaining to announcements of meetings and other committee management activities, for both the Centers for Disease Control and Prevention and the Agency for Toxic Substances and Disease Registry. Elaine L. Baker, Acting Director, Management Analysis and Services Office, Centers for Disease Control and Prevention. [FR Doc. 2016–09269 Filed 4–20–16; 8:45 am] BILLING CODE 4163–18–P PO 00000 Frm 00043 Fmt 4703 Sfmt 4703 [30Day–16–1061] The Centers for Disease Control and Prevention (CDC) has submitted the following information collection request to the Office of Management and Budget (OMB) for review and approval in accordance with the Paperwork Reduction Act of 1995. The notice for the proposed information collection is published to obtain comments from the public and affected agencies. Written comments and suggestions from the public and affected agencies concerning the proposed collection of information are encouraged. Your comments should address any of the following: (a) Evaluate whether the proposed collection of information is necessary for the proper performance of the functions of the agency, including whether the information will have practical utility; (b) Evaluate the accuracy of the agencies estimate of the burden of the proposed collection of information, including the validity of the methodology and assumptions used; (c) Enhance the quality, utility, and clarity of the information to be collected; (d) Minimize the burden of the collection of information on those who are to respond, including through the use of appropriate automated, electronic, mechanical, or other technological collection techniques or other forms of information technology, e.g., permitting electronic submission of responses; and (e) Assess information collection costs. To request additional information on the proposed project or to obtain a copy of the information collection plan and instruments, call (404) 639–7570 or send an email to omb@cdc.gov. Written comments and/or suggestions regarding the items contained in this notice should be directed to the Attention: CDC Desk Officer, Office of Management and Budget, Washington, DC 20503 or by fax to (202) 395–5806. Written comments should be received within 30 days of this notice. Proposed Project Behavioral Risk Factor Surveillance System (BRFSS) (OMB Control No. 0920–1061, exp. 3/31/2018)— Revision—National Center for Chronic Disease Prevention and Health Promotion (NCCDPHP)—Centers for Disease Control and Prevention (CDC). E:\FR\FM\21APN1.SGM 21APN1 23499 Federal Register / Vol. 81, No. 77 / Thursday, April 21, 2016 / Notices Background and Brief Description CDC is requesting OMB approval to revise information collection for the Behavioral Risk Factor Surveillance System (BRFSS). The BRFSS is a nationwide system of annual, crosssectional telephone health surveys sponsored by CDC. BRFSS coordinators in health departments in U.S. states, territories, and the District of Columbia (collectively referred to as states) collaborate with CDC on questionnaire content and survey administration. An independent sample of adult, noninstitutionalized respondents is drawn each for each state and is based on the state’s parameters for state-level or substate analysis. Each state’s annual questionnaire is based on a common core that is administered by all states. In addition, CDC provides support for standardized optional modules that states can use to collect customized content. Information collection is conducted in a continuous, three-part telephone interview process: Screening, participation in core BRFSS questions, and participation in the optional question modules. Both the core survey and the optional modules are updated annually. CDC requests OMB approval to incorporate a limited annual field test into the BRFSS clearance. Field testing will be conducted approximately 5–8 months in advance of the principal BRFSS survey. Field tests are used to identify problems with new or updated questions, instrument documentation or instructions, software errors, or other implementation issues. Field tests are typically conducted in one state. Addition of the annual field test will increase the estimated annualized number of responses by 900 and the estimated annualized burden by 382 hours. These estimates include allocations for both respondent screening and completion of the field test survey. Each year CDC will use the Change Request mechanism to request OMB approval of the annual Field Test Supplement. CDC and the states will continue to use BRFSS data to produce state-level information about adults 18 years and older. BRFSS topics include health risk behaviors, health conditions, and preventive health practices that are associated with chronic diseases, infectious diseases, and injury. This information is used by state and local health departments to plan and evaluate public health programs at the state or sub-state level. In addition, CDC makes annual BRFSS data sets available for public use and provides guidance on statistically appropriate uses of the data. Field test results will not be incorporated into the analytic data sets. Field test results are used exclusively to inform the development of the upcoming year’s BRFSS questionnaire and the technical assistance that CDC provides to states. OMB approval is requested for three years. Participation in the BRFSS is voluntary and there are no costs to respondents other than their time. The total estimated annualized burden hours are 256,297. ESTIMATED ANNUALIZED BURDEN HOURS Number of respondents Type of respondents Form name U.S. General Population ................................. Landline Screener .......................................... Cell Phone Screener ...................................... Field Test Screener ........................................ Core Survey ................................................... Optional Modules ........................................... Field Test Survey ........................................... Adults ≥18 Years ............................................ Leroy A. Richardson, Chief, Information Collection Review Office, Office of Scientific Integrity, Office of the Associate Director for Science, Office of the Director, Centers for Disease Control and Prevention. [FR Doc. 2016–09189 Filed 4–20–16; 8:45 am] BILLING CODE 4163–18–P DEPARTMENT OF HEALTH AND HUMAN SERVICES Food and Drug Administration jstallworth on DSK7TPTVN1PROD with NOTICES [Docket No. FDA–2016–N–0832] FOR FURTHER INFORMATION CONTACT: Phibro Animal Health Corp.; Carbadox in Medicated Swine Feed; Opportunity for Hearing; Correction AGENCY: Food and Drug Administration, HHS. Notice of opportunity for hearing; correction. ACTION: The Food and Drug Administration (FDA) is correcting a SUMMARY: VerDate Sep<11>2014 13:27 Apr 20, 2016 Jkt 238001 notice that appeared in the Federal Register on April 12, 2016 (81 FR 21559). The document announced an opportunity for a hearing on FDA’s Center for Veterinary Medicine’s proposal to withdraw approval of all new animal drug applications providing for use of carbadox in medicated swine feed and contained an incorrect telephone number for the individual to be contacted for further information. The address for Phibro Animal Health Corp. was also incorrect. This document corrects those errors. Vernon Toelle, Center for Veterinary Medicine (HFV–234), 7519 Standish Pl., Rockville, MD 20855, 240–402–7001. In FR Doc. 2016–08327, appearing on page 21559 in the Federal Register of Tuesday, April 12, 2016, the following corrections are made: 1. On page 21560, in the second column, in the FOR FURTHER SUPPLEMENTARY INFORMATION: PO 00000 Frm 00044 Fmt 4703 Sfmt 9990 Number of responses per respondent 440,486 223,334 400 494,650 484,757 500 Average burden per response (in hr) 1 1 1 1 1 1 1/60 1/60 1/60 15/60 15/60 45/60 paragraph, the telephone number is corrected to read ‘‘240–402–7001’’. 2. On page 21560, in the third column, in the first paragraph, the address for Phibro Animal Health Corp. is corrected to read ‘‘GlenPointe Centre East, 3d floor, 300 Frank W. Burr Blvd., suite 21, Teaneck, NJ 07666’’. 3. On page 21572, in the first column, in the third paragraph, the address for Phibro Animal Health Corp. is corrected to read ‘‘GlenPointe Centre East, 3d floor, 300 Frank W. Burr Blvd., suite 21, Teaneck, NJ 07666’’. INFORMATION CONTACT Dated: April 18, 2016. Tracey Forfa, Acting Director, Center for Veterinary Medicine. [FR Doc. 2016–09265 Filed 4–20–16; 8:45 am] BILLING CODE 4164–01–P E:\FR\FM\21APN1.SGM 21APN1

Agencies

[Federal Register Volume 81, Number 77 (Thursday, April 21, 2016)]
[Notices]
[Pages 23498-23499]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2016-09189]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

Centers for Disease Control and Prevention

[30Day-16-1061]


Agency Forms Undergoing Paperwork Reduction Act Review

    The Centers for Disease Control and Prevention (CDC) has submitted 
the following information collection request to the Office of 
Management and Budget (OMB) for review and approval in accordance with 
the Paperwork Reduction Act of 1995. The notice for the proposed 
information collection is published to obtain comments from the public 
and affected agencies.
    Written comments and suggestions from the public and affected 
agencies concerning the proposed collection of information are 
encouraged. Your comments should address any of the following: (a) 
Evaluate whether the proposed collection of information is necessary 
for the proper performance of the functions of the agency, including 
whether the information will have practical utility; (b) Evaluate the 
accuracy of the agencies estimate of the burden of the proposed 
collection of information, including the validity of the methodology 
and assumptions used; (c) Enhance the quality, utility, and clarity of 
the information to be collected; (d) Minimize the burden of the 
collection of information on those who are to respond, including 
through the use of appropriate automated, electronic, mechanical, or 
other technological collection techniques or other forms of information 
technology, e.g., permitting electronic submission of responses; and 
(e) Assess information collection costs.
    To request additional information on the proposed project or to 
obtain a copy of the information collection plan and instruments, call 
(404) 639-7570 or send an email to omb@cdc.gov. Written comments and/or 
suggestions regarding the items contained in this notice should be 
directed to the Attention: CDC Desk Officer, Office of Management and 
Budget, Washington, DC 20503 or by fax to (202) 395-5806. Written 
comments should be received within 30 days of this notice.

Proposed Project

    Behavioral Risk Factor Surveillance System (BRFSS) (OMB Control No. 
0920-1061, exp. 3/31/2018)--Revision--National Center for Chronic 
Disease Prevention and Health Promotion (NCCDPHP)--Centers for Disease 
Control and Prevention (CDC).

[[Page 23499]]

Background and Brief Description

    CDC is requesting OMB approval to revise information collection for 
the Behavioral Risk Factor Surveillance System (BRFSS). The BRFSS is a 
nationwide system of annual, cross-sectional telephone health surveys 
sponsored by CDC. BRFSS coordinators in health departments in U.S. 
states, territories, and the District of Columbia (collectively 
referred to as states) collaborate with CDC on questionnaire content 
and survey administration.
    An independent sample of adult, non-institutionalized respondents 
is drawn each for each state and is based on the state's parameters for 
state-level or sub-state analysis. Each state's annual questionnaire is 
based on a common core that is administered by all states. In addition, 
CDC provides support for standardized optional modules that states can 
use to collect customized content. Information collection is conducted 
in a continuous, three-part telephone interview process: Screening, 
participation in core BRFSS questions, and participation in the 
optional question modules. Both the core survey and the optional 
modules are updated annually.
    CDC requests OMB approval to incorporate a limited annual field 
test into the BRFSS clearance. Field testing will be conducted 
approximately 5-8 months in advance of the principal BRFSS survey. 
Field tests are used to identify problems with new or updated 
questions, instrument documentation or instructions, software errors, 
or other implementation issues. Field tests are typically conducted in 
one state. Addition of the annual field test will increase the 
estimated annualized number of responses by 900 and the estimated 
annualized burden by 382 hours. These estimates include allocations for 
both respondent screening and completion of the field test survey. Each 
year CDC will use the Change Request mechanism to request OMB approval 
of the annual Field Test Supplement.
    CDC and the states will continue to use BRFSS data to produce 
state-level information about adults 18 years and older. BRFSS topics 
include health risk behaviors, health conditions, and preventive health 
practices that are associated with chronic diseases, infectious 
diseases, and injury. This information is used by state and local 
health departments to plan and evaluate public health programs at the 
state or sub-state level. In addition, CDC makes annual BRFSS data sets 
available for public use and provides guidance on statistically 
appropriate uses of the data.
    Field test results will not be incorporated into the analytic data 
sets. Field test results are used exclusively to inform the development 
of the upcoming year's BRFSS questionnaire and the technical assistance 
that CDC provides to states.
    OMB approval is requested for three years. Participation in the 
BRFSS is voluntary and there are no costs to respondents other than 
their time. The total estimated annualized burden hours are 256,297.

                                        Estimated Annualized Burden Hours
----------------------------------------------------------------------------------------------------------------
                                                                                     Number of    Average burden
          Type of respondents                   Form name            Number of     responses per   per response
                                                                    respondents     respondent        (in hr)
----------------------------------------------------------------------------------------------------------------
U.S. General Population...............  Landline Screener.......         440,486               1            1/60
                                        Cell Phone Screener.....         223,334               1            1/60
                                        Field Test Screener.....             400               1            1/60
Adults >=18 Years.....................  Core Survey.............         494,650               1           15/60
                                        Optional Modules........         484,757               1           15/60
                                        Field Test Survey.......             500               1           45/60
----------------------------------------------------------------------------------------------------------------


Leroy A. Richardson,
Chief, Information Collection Review Office, Office of Scientific 
Integrity, Office of the Associate Director for Science, Office of the 
Director, Centers for Disease Control and Prevention.
[FR Doc. 2016-09189 Filed 4-20-16; 8:45 am]
 BILLING CODE 4163-18-P
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.